Crizotinib-induced esophageal ulceration: a novel adverse event of crizotinib.
This report describes esophageal ulcer as a novel adverse event associated with crizotinib therapy. Although crizotinib is generally well tolerated, physicians should be aware of the possibility of this adverse event.